about
Epigenetic modifications and diabetic retinopathyIncretin-Based Therapy for Prevention of Diabetic Vascular ComplicationsOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetesPotential Role of Protein Disulfide Isomerase in Metabolic Syndrome-Derived Platelet HyperactivityThe association of normal range glycated hemoglobin with restrictive lung pattern in the general populationClinical therapeutic strategies for early stage of diabetic kidney disease.The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetesGlucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnosticsConditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of DiabetesConsumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes.Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuriaSirtuins and renal diseases: relationship with aging and diabetic nephropathy.The Diabetes Visual Function Supplement Study (DiVFuSS)Non-invasive measurement of skin autofluorescence to evaluate diabetic complications.Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award LectureNailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy.Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.Renal protective effects of resveratrol.Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.Natural polyphenols based new therapeutic avenues for advanced biomedical applications.Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.Diabetic retinopathy: Breaking the barrier.p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin.Dihydroxyacetone induces G2/M arrest and apoptotic cell death in A375P melanoma cells.Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Implications of impaired zinc homeostasis in diabetic cardiomyopathy and nephropathy.Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat.Interaction of diabetes and smoking on stroke: a population-based cross-sectional survey in China.
P2860
Q21284810-A6B1C57E-D651-4B36-BED7-1641301397B1Q26765470-EA7BBEC4-2815-4BE2-9849-CBF82E8D2604Q27022467-11BFEB4F-1A79-476E-AFB1-57BF3F50F811Q28077101-B4EC7A64-67A1-4D79-8B61-6C063516553AQ28354107-D55D3EA8-D06A-4E57-AFD9-8556A4B8E40DQ28543247-A3316EFB-244E-47BA-8BFF-B3D992FD390CQ30363683-FED8ECB9-E18F-443C-A942-02FE5D7C77B4Q30401960-8B8D8D28-9E4A-4FD2-8B90-8CDA1DE3F0DAQ33603384-B921535B-656A-424F-84AA-578FD1352C18Q35189544-BDB6583A-8C86-4D76-AEA8-813CC9EA939AQ35912202-664E0833-A729-4B7D-B67A-8600C656B953Q36102156-ABC4C28D-AFCE-4BF2-9174-068954E3D929Q36269724-8344B266-4959-4EB2-92D2-299A838D5912Q36304756-9031FEE4-FB1D-485E-8DF2-96CE30661CDFQ36577211-641C4859-92B7-47D2-BD36-6F71C4901A0EQ36677588-8523CDFC-7F60-47A8-880F-E11AF641B83EQ36930826-4925D524-1E6A-4D71-BCFC-49509A9F93E1Q37552158-78C826A9-2AEC-4A0A-B7DE-C22924B3425EQ38162106-79F71E2E-70DC-41AC-ABD5-32EEAFA9DA12Q38174888-3DC15551-BF77-48C6-9BD9-8FA8AC8CB588Q38463463-B1145D04-667B-4F3C-867B-D670CD1415A8Q38622865-D144D133-1759-4847-8CD7-FAAD7A0D6FB8Q39358954-19278516-46E6-4765-A18A-3FFB2E154ACAQ39451009-6B0C8803-6002-46B4-AC34-C934B6700C49Q41491502-94DEE985-2FED-40D2-895A-300B8143399EQ46250387-47DE0520-B738-4C6E-B933-62F8CEF66D5FQ46312225-D6CE0B8F-6B8E-4FA0-960A-DF8EC0EAF9C7Q47094741-02F7A285-98FD-410A-ADF1-499081E5BE6BQ47739163-2CF8699F-3306-474A-AF6C-43205874A748Q48169638-9DB91275-7625-4E81-8EBA-E5874E94A18EQ51302987-1D8874F6-E29D-496A-AA45-BA5580661785Q53832323-8ADA9B92-3C57-4354-8B5C-3217F15B76BD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Molecular mechanisms of diabetic vascular complications
@ast
Molecular mechanisms of diabetic vascular complications
@en
Molecular mechanisms of diabetic vascular complications.
@nl
type
label
Molecular mechanisms of diabetic vascular complications
@ast
Molecular mechanisms of diabetic vascular complications
@en
Molecular mechanisms of diabetic vascular complications.
@nl
prefLabel
Molecular mechanisms of diabetic vascular complications
@ast
Molecular mechanisms of diabetic vascular complications
@en
Molecular mechanisms of diabetic vascular complications.
@nl
P2093
P2860
P1476
Molecular mechanisms of diabetic vascular complications
@en
P2093
Akira Mima
George L King
Munehiro Kitada
Zhaoyun Zhang
P2860
P356
10.1111/J.2040-1124.2010.00018.X
P577
2010-06-01T00:00:00Z